Synthesis 2015; 47(16): 2414-2430
DOI: 10.1055/s-0034-1378736
special topic
© Georg Thieme Verlag Stuttgart · New York

Isocyanide-Based Multicomponent Reactions: Rapid Synthesis of a 5,5-Fused Bicyclic Skeleton from α,β-Unsaturated Ketones and Allenoates

Shibo Xu
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Shikuan Su
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Huiting Zhang
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Lumin Tian
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Pengcheng Liang
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Jiawen Chen
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Yuan Zhang
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Chunju Li
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
,
Xueshun Jia*
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
b   State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, 730000, P. R. of China
,
Jian Li*
a   Department of Chemistry, Shanghai University, Shanghai, 200444, P. R. of China   Email: xsjia@mail.shu.edu.cn   Email: lijian@shu.edu.cn
› Author Affiliations
Further Information

Publication History

Received: 17 April 2015

Accepted after revision: 05 June 2015

Publication Date:
24 July 2015 (online)

 


Abstract

An efficient multicomponent reaction of isocyanides, allenoates, and α,β-unsaturated ketones is disclosed, thus providing rapid access for the synthesis of bicyclic skeletons. From a mechanistic standpoint, the present cycloaddition proceeds through cascade cycloaddition followed by hydration and intramolecular cyclization. Several controlled experiments are also conducted to gain further insight into the reaction mechanism; some valuable and interesting findings were observed during this process. To enrich the structural diversity, 3-(2-oxo­ethylene)indolinones (i.e. with an α,β-unsaturated ketone at position 3) were also found to be compatible in this reaction. In addition, this method is also characterized by its broad substrate scope, mild conditions, and high efficiency, which makes it valuable for further application.


#

Isocyanides represent highly valuable C1 building blocks and they have attracted much attention from synthetic chemists due to their ready availability and versatile reactivity.[2] For instance, isocyanides are excellent substrates in the construction of many nitrogen-containing heterocycles.[3] More recently, the transition-metal-catalyzed insertion and some radical-based transformations involving isocyanide have also enjoyed considerable interest from the synthetic community.[4] [5] On the other hand, the exceptional divalent carbon atom of isocyanides[6] makes them particularly flexible partners in multicomponent reactions.[7] In general, isocyanide-based multicomponent reactions (IMCRs) are superior in many respects to traditional methods in terms of good atom- and step-economy together with convergence.[8] Furthermore, IMCRs also have the possibility to attain molecular complexity and diversity in a single step,[9] which is of great significance for the construction of small-molecule libraries. As a result, a series of novel and highly efficient IMCRs reactions have been well documented.[10] Regardless of the great achievements realized in this field, the development of new IMCRs to ensure sufficient molecular diversity and complexity remains desirable.

Recently, we have focused our attention on exploring the potential synthetic utility of a novel multicomponent cycloaddition strategy involving isocyanide and allenoate. The first example dates back to 2011 when we published pioneering work, thus offering a new method for the construction of spiro-oxindole derivatives.[11]

Until now, several efficient and rapid approaches for the synthesis of functionalized carbocycles and natural-product-like N-containing heterocycles have been reported.[12] The mechanistic analysis based on these outcomes demonstrates that these multicomponent reactions have two typical pathways (Scheme [1]). The beginning of both transformations involves the formation of a reactive zwitterion generated from the Michael addition of isocyanide and allenoate. The resonance-stabilized species can be easily trapped by the electron-deficient species to form five-membered carbocycles and heterocycles, thus providing a so-called [2+2+1] cycloaddition (path a).[12a] [b] Recently, we have also found that the capture of this zwitterionic intermediate can be utilized to construct structurally complex bicyclic skeletons. Mechanistically, the formation of the first five-membered carbocycle is still a [2+2+1] cycloaddition, but the presence of α-substituents in the allenoate can induce a special [1,5]-hydride shift, which is considered to be the key step for the whole conversion (path b).[12c,d] As a bonus to this isocyanide-based multicomponent reaction system, we found that a third reaction route existed, which could be used to construct structurally unusual bicyclic skeletons. Remarkably, the cascade cycloaddition starts from a formal [3+2] cycloaddition, which is different from the previously reported examples (path c). As a continuation of our ongoing research program, we herein report that the combination of isocyanide, allenoate, and α,β-unsaturated ketones in the presence of water provides rapid access to bicyclic pyrrolidine-2,5-diones derivatives.

Zoom Image
Scheme 1 Representative multicomponent cycloadditions based on isocyanide and allenoate in the presence of electron-deficient species

The initial experiment was performed with tert-butyl isocyanide (1a), ethyl 2-benzylbuta-2,3-dienoate (2a), chalcone (3a), and water as a model reaction (Table [1]). Simply heating the mixture under reflux directly produced bicyclic cycloadduct 4a in 56% yield (entry 1). Various aliphatic and aromatic isocyanides participated in this cascade cycloaddition reaction under reflux conditions, thereby affording the corresponding fused skeletons 4 in satisfactory yields (see the Supporting Information for details). The experimental results revealed that the present reaction is not sensitive to steric hindrance in the alkyl isocyanide component. For instance, tert-butyl and 1,1,3,3-tetramethylbutyl groups were compatible with this transformation (entries 1 and 4). A good result was also obtained when admantan-1-yl isocyanide (1g) was used (entry 7).

Table 1 Multicomponent Cycloaddition Reaction of Isocyanide 1, Ethyl 2-Benzylbuta-2,3-dienoate (2a), and Chalcone (3a)a

Entry

R

Product

Yieldb (%)

1

t-Bu

4a

56

2

Bu

4b

52

3

Cy

4c

42

4

CMe2CH2 t-Bu

4d

62

5

i-Pr

4e

37

6

Bn

4f

71

7

4g

55

8c

2,6-Me2C6H3

4h

23

9c

2-Cl-6-MeC6H3

4i

41

a Reaction conditions: 1 (0.5 mmol), 2a (0.6 mmol), 3a (0.5 mmol), toluene–H2O (6:1, 5 mL), reflux, 12 h.

b Yields of product after silica gel chromatography.

c The reaction time was prolonged to 24 h.

Reactions with other aromatic isocyanides were also tried subsequently. While 2-chloro-6-methylphenyl isocyanide (1i) reacted smoothly under these conditions, the use of 2,6-dimethylphenyl isocyanide (1h) only led to a low yield of 4h albeit with long reaction time (Table [1], entries 7 and 8). It is also worthy of note that temperature has an important influence on the reaction performance. For example, the reaction yield decreased dramatically (< 10%) when the reaction was conducted at lower temperature (80 °C). In contrast, better yields were obtained when the temperature was increased; finally, reflux conditions were selected as the best choice.

After a broad isocyanide scope had been established, we then turned our attention to the feasibility of substituted allenoates. As shown in Table [2, a] variety of allenoates 2 having electron-withdrawing (entries 1–6) and electron-donating groups (entries 7–9) on the phenyl ring of the benzyl group were employed to react with 1,1,3,3-tetramethylbutyl isocyanide (1d) and chalcone (3a) under the standard reaction conditions. To our delight, most substituents were well tolerated giving the corresponding products 5. For example, the reaction with ethyl 2-(3-chlorobenzyl)allenoate 2c furnished the cycloadduct 5c in 76% yield (entry 3). Ethyl 2-methylallenoate 2j was also compatible with the cycloaddition reaction giving 5j in 45% yield (entry 10). The structure of compound 5d was unambiguously confirmed by single crystal X-ray analysis (Figure [1]).[13] Notably, this protocol represents a practical and efficient multicomponent example for the construction of complex bicyclic skeletons. In particular, 2-alkylallenoates act as a 4C synthon to form two fused rings, which demonstrated good synthetic efficiency since allenoates are often used as a 2C or 3C building block in cycloaddition reactions.

Table 2 Multicomponent Cascade Cycloaddition of 1,1,3,3-Tetra­meth­yl­butyl Isocyanide (1d), Substituted Allenoate 2, and Chalcone (3a)a

Entry

R1

Product

Yieldb (%)

 1

3-FC6H4CH2

5a

61

 2

4-ClC6H4CH2

5b

46

 3

3-ClC6H4CH2

5c

76

 4

4-BrC6H4CH2

5d

52

 5

4-O2NC6H4CH2

5e

36

 6

3-O2NC6H4CH2

5f

50

 7

4-MeC6H4CH2

5g

57

 8

3-MeC6H4CH2

5h

61

 9

4-MeOC6H4CH2

5i

64

10

Me

5j

45

11

CH2CO2Me

5k

47

12

CH2CO2Et

5l

51

a Reaction conditions: 1d (0.5 mmol), 2 (0.6 mmol), 3a (0.5 mmol), toluene–H2O (6:1, 5 mL), reflux.

b Yields of product after silica gel chromatography.

Zoom Image
Figure 1 X-ray crystal structure of product 5d

A series of substituted α,β-unsaturated ketones 3 were next examined with 1,1,3,3-tetramethylbutyl isocyanide (1d) and ethyl 2-benzylbuta-2,3-dienoate (2a) to further explore the versatility of this multicomponent cycloaddition strategy (Table [3]). Pleasingly, all reactions worked well to afford cycloadducts 6 in satisfactory yields. The structure of compound 6l was unambiguously confirmed by single crystal X-ray analysis.[14]

Table 3 Multicomponent Reaction of 1,1,3,3-Tetramethylbutyl Isocyanide (1d), Ethyl 2-Benzylbuta-2,3-dienoate (2a), and α,β-Unsaturated Ketone 3 a

Entry

R2

R3

Product

Yieldb (%)

 1

Ph

4-FC6H4

6a

53

 2

Ph

4-ClC6H4

6b

61

 3

Ph

3-ClC6H4

6c

58

 4

Ph

4-BrC6H4

6d

56

 5

Ph

4-MeC6H4

6e

65

 6

Ph

4-MeOC6H4

6f

38

 7

Ph

1-naphthyl

6g

40

 8

4-ClC6H4

Ph

6h

48

 9

4-BrC6H4

Ph

6i

51

10

4-MeC6H4

Ph

6j

50

11

4-MeOC6H4

Ph

6k

56

12

styryl

Ph

6l

49

a Reaction conditions: 1d (0.5 mmol), 2a (0.6 mmol), 3 (0.5 mmol), toluene–H2O (6:1, 5 mL), reflux, 12 h.

b Yields of product after silica gel chromatography.

The mechanism of this cycloaddition reaction has not been unequivocally established, but the formation of the bicyclic skeleton may be rationalized as illustrated in Scheme [2]. The cyclization process is triggered by the nucleophilic attack of isocyanide 1 toward allenoate 2, thus affording resonance-stabilized zwitterionic species AB.[12] This very reactive intermediate is then trapped by the electron-deficient C=C bond to produce key intermediate C. After that, two possible pathways may exist. According to path a, the intramolecular Michael addition takes place firstly to form reactive ketenimine D.[15] Subsequently, nucleophilic attack by water on the central position of the ketenimine essentially leads to the formation of cyclized intermediate E. The elimination of ethanol and tautomerization then occur to produce the final cycloadduct 4 or 5. Another pathway b is also reasonable. In this case, the nitrene intermediate is firstly captured by water to give F.[16] Finally, intramolecular proton transfer followed by cyclization will take place to give the final product 4 or 5. For the present, neither of the routes can be ruled out.

Zoom Image
Scheme 2 Proposed mechanism

An isotope-labeling experiment was subsequently conducted to gain further insight into the reaction mechanism. As shown in Scheme [3], the corresponding O18-labeled cycloadduct 4a′ was isolated when H2O18 rather than H2O was used as a component. However, a lower yield was observed, albeit with a prolonged reaction time (36 h). Meanwhile, the same reaction was also performed without the addition of water. In this case, no bicyclic product 4a was observed. These experimental findings revealed that the presence of water is necessary for ring formation.

Zoom Image
Scheme 3 Controlled experiments

Since the spiro-oxindole derivatives are privileged skeleton in natural products with well-known biological activity,[17] [18] we thus attempted to test the reactivity of meth­yleneindolinones 7 (derived from oxindole and acetophenone) in this cycloaddition (Table [4]).

Table 4 Multicomponent Reaction of 2,6-Dimethylphenyl Isocyanide (1h), α-Substituted Allenoate 2, and Methyleneindolinone 7 a

Entry

R1

R4

R5

Product

Yieldb (%)

1

Me

H

Ph

8a

35

2

Me

H

4-ClC6H4

8b

42

3

Me

H

3-ClC6H4

8c

36

4

Me

H

4-BrC6H4

8d

52

5

Me

H

4-O2NC6H4

8e

21

6

Me

H

4-MeC6H4

8f

45

7

H

H

4-MeOC6H4

8g

55

8

Me

H

4-PhC6H4

8h

38

9

Bn

H

Ph

8i

36

10

3-FC6H4CH2

H

Ph

8j

50

11

3-ClC6H4CH2

H

Ph

8k

39

12

CH2CO2Et

H

Ph

8l

58

13

Me

4-Br

Ph

8m

45

14

Me

5-Cl

Ph

8n

34

a Reaction conditions: 1h (0.5 mmol), 2 (0.6 mmol), 7 (0.5 mmol), toluene–H2O (6:1, 5 mL), reflux, 24 h.

b Yields of product after silica gel chromatography.

c The time was prolonged to 36 h.

As we can see, the structure of substrate 7 features the α,β-unsaturated ketone unit at position 3 of the oxindole. To further establish the scope and limitations of this method, 2,6-dimethylphenyl isocyanide (1h) and substituted allenoate 2 were selected as reaction partners. The experimental results showed that this reaction has a broad scope with regard to the variation of allenoate 2 and methyleneindolinone 7. The structure of compound 8a was unambiguously confirmed by single crystal X-ray analysis.[19]

Other isocyanides were also employed under the standard conditions. The corresponding products were obtained in satisfactory yields when 2-chloro-6-methylphenyl and 2,6-diisopropylphenyl isocyanides were used (Scheme [4]). The easy variation of isocyanide component makes the present reaction more flexible, which is important to the fast and efficient construction of the corresponding compound library.

As we can see from these experimental results, reactions with 3-(2-oxoethylene)indolinones 7 demonstrated different regioselectivity compared to α,β-unsaturated ketones 3 (Scheme [5]). According to our mechanistic proposal, Michael addition will take place followed by formation of a reactive zwitterionic species. When the α,β-unsaturated ketones 3 were used, the nucleophilic addition started from the exocyclic vinyl carbon.[20] In contrast, the nucleophilic site transferred to another side when methyleneindolinones 7 were used. As a result, the steric hindrance plays a key role in the reaction behavior.

Zoom Image
Scheme 4 Construction of spirocyclic oxindole 8 with aromatic isocyanides
Zoom Image
Figure 2 X-ray crystal structure of product 9a

To our surprise, we also observed several interesting experimental results. As shown in Scheme [6], upon treatment of 2,6-diisopropylphenyl isocyanide (1j) with allenoate 2j and methyleneindolinone 7a under the standard reaction conditions, monocyclic compound 9a was unexpectedly isolated as side product. In addition, an analogous structure was obtained as the major product when 2,6-dimethylphenyl isocyanide (1h) reacted with methyl-substituted allenoate 2j and methyleneindolinone 7o.

Notably, the structure of compound 9a was unambiguously confirmed by single crystal X-ray analysis (Figure [2]).[21] It should be pointed out that the structure of 9 is quite strange at first glance. It seemed that an unusual ester group migration is involved, which is different from that described in the mechanism (Scheme [2]).

Based on these experimental outcomes, a reasonable possibility is outlined to explain the formation of compound 9 (Scheme [7]). As we have discussed, the reaction begins with [3+2] cycloaddition.[22] Accordingly, the blending of substrate 1, 2j, and 7 gives rise to intermediate H, which contains a reactive ketenimine unit. Subsequently, the nucleophilic attack of water followed by intramolecular cyclization yields intermediate J. Then the elimination of the ethoxy anion will take place to afford K. In this case, the nucleophilic ethoxy anion can attack the protonated carbonyl group, thus affording a new intermediate L. The ring opening followed by proton transfer finally gives the unexpected product 9.

Zoom Image
Scheme 5 Different regioselectivity observed during the Michael addition with substrates 7 and 3

According to our analysis, the formation of product 9 and 8 may come from the same intermediate. At the beginning, we had no evidence for our hypothesis until we found that compound 9 could be converted into compound 8 under appropriate conditions. Initially, compound 9a was preserved in a NMR tube with CDCl3. To our surprise, we found that compound 9a was completely transformed into compound 8r after about two weeks (Scheme [8]). Undoubtedly, the weak acidic environment plays an important role in this conversion. This finding allows us to have better understanding of this multicomponent cycloaddition.

In conclusion, we have described a novel multicomponent reaction of isocyanide, substituted allenoate, and α,β-unsaturated ketone. This method also provides a rapid access for the synthesis of complex bicyclic skeletons. Mechanistically, the cascade sequence may proceed through multiple Michael addition, hydration, and intramolecular cyclization. Several valuable findings are observed following the controlled experiments, thus we have further insight into the reaction mechanism. The present reaction has a broad substrate scope, which is significant for the construction of the corresponding compound library. During our investigation, we also found that the allenoate acts as a 4C synthon for the construction of the rings, which represents high synthetic efficiency.[23] Further works may include the investigation on structure-activity relationship (SAR).

The NMR spectra were recorded on 500 MHz spectrometer (500 MHz for 1H NMR and 125 MHz for 13C NMR) with CDCl3 as the solvent and TMS as internal reference. IR spectra were recorded on a FT-IR spectrophotometer. HRMS were recorded on a FTMS instrument in ESI mode. Melting points were obtained on digital melting point apparatus without correction. Unless otherwise stated, all reagents were commercially purchased and used without further purification. Aromatic isocyanides 1 were prepared from the corresponding anilines according to the method disclosed by Ugi with a slight modification.[24] All substituted allenoates 2 were synthesized according to procedures reported previously.[25] All α,β-unsaturated ketones 3 and 3-(2-aryl-2-oxoethylene)oxindoles 7 were synthesized according to the literature.[26] [27] [28]

Zoom Image
Scheme 6 Formation of an interesting product 9
Zoom Image
Scheme 7 Proposed mechanism for the formation of compound 9
Zoom Image
Scheme 8 Conversion between compound 9 and 8

#

2-Substituted 4-Benzoyl-3a-benzyl-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-diones 4; General Procedure

To a solution of isocyanide 1 (0.5 mmol) and substituted allenoate 2a (0.6 mmol) in a mixed solvent toluene–H2O (6:1, 5 mL), α,β-unsaturated ketones 3a (0.5 mmol) was added under a N2 atmosphere. The mixture was stirred under reflux for several hours (TLC monitoring). When the reaction was complete, the mixture was concentrated under vacuum. The residue was purified by column chromatography (silica gel 200–300, petroleum ether–EtOAc) to afford the product 4.


#

4-Benzoyl-3a-benzyl-2-tert-butyl-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4a)

Pale yellow oil; yield: 130.2 mg (56%).

1H NMR (500 MHz, CDCl3): δ = 7.83 (d, J = 7.0 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.27–7.10 (m, 10 H), 4.06 (d, J = 11.0 Hz, 1 H), 3.67–3.61 (m, 1 H), 3.42 (d, J = 13.0 Hz, 1 H), 3.04 (d, J = 8.0 Hz, 1 H), 2.86 (d, J = 13.5 Hz, 1 H), 2.58 (dd, J = 13.0, 6.0 Hz, 1 H), 2.20–2.13 (td, J = 13.0, 9.0 Hz, 1 H), 1.53 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.7, 179.5, 179.4, 140.1, 139.1, 136.1, 133.1, 130.2, 128.7, 128.7, 128.6, 128.2, 127.4, 127.1, 127.1, 63.0, 59.8, 59.0, 48.7, 47.4, 42.3, 35.7, 28.3.

HRMS (ESI): m/z [M + Na]+ calcd for C31H31NNaO3: 488.2202; found: 488.2195.


#

4-Benzoyl-3a-benzyl-2-butyl-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4b)

White solid; yield: 120.9 mg (52%); mp 158–159 °C.

1H NMR (500 MHz, CDCl3): δ = 7.85 (d, J = 7.5 Hz, 2 H), 7.56 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.25–7.08 (m, 10 H), 4.11 (d, J = 11.5 Hz, 1 H), 3.66–3.59 (m, 1 H), 3.47–3.42 (m, 3 H), 3.21 (d, J = 8.5 Hz, 1 H), 2.93 (d, J = 13.5 Hz, 1 H), 2.62 (dd, J = 13.5, 6.0 Hz, 1 H), 2.27–2.20 (td, J = 13.5, 9.0 Hz, 1 H), 1.49–1.40 (m, 2 H), 1.21–1.08 (m, 2 H), 0.88 (t, J = 7.0 Hz, 3 H).

13C NMR (125 MHz, CDCl3): δ = 199.6, 178.4, 178.3, 139.8, 139.0, 135.7, 133.2, 130.1, 128.7, 128.7, 128.2, 127.5, 127.2, 127.1, 62.8, 60.7, 48.7, 47.6, 42.1, 39.1, 35.2, 29.6, 19.9, 13.6.

HRMS (ESI): m/z [M + Na]+ calcd for C31H31NNaO3: 488.2202; found: 488.2198.


#

4-Benzoyl-3a-benzyl-2-cyclohexyl-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4c)

White solid; yield: 103.1 mg (42%); mp 207–208 °C.

1H NMR (500 MHz, CDCl3): δ = 7.86 (d, J = 7.0 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.25–7.08 (m, 10 H), 4.09 (dd, J = 11.0, 5.0 Hz, 1 H), 3.92–3.87 (m, 1 H), 3.64–3.58 (m, 1 H), 3.44 (d, J = 13.5 Hz, 1 H), 3.11 (d, J = 9.0 Hz, 1 H), 2.89 (d, J = 13.5 Hz, 1 H), 2.60 (dd, J = 13.0, 6.0 Hz, 1 H), 2.25–2.18 (m, 1 H), 2.09 (m, 2 H), 1.81 (t, J = 13.5 Hz, 2 H), 1.63 (d, J = 11.0 Hz, 1 H), 1.53 (t, J = 13.5 Hz, 2 H), 1.29–1.19 (m, 3 H).

13C NMR (125 MHz, CDCl3): δ = 199.5, 178.6, 178.4, 139.9, 139.0, 135.9, 133.2, 130.1, 128.7, 128.7, 128.2, 127.5, 127.1, 127.1, 62.9, 60.0, 52.2, 48.4, 47.5, 42.2, 35.41, 28.7, 28.6, 25.9, 25.8, 25.1.

HRMS (ESI): m/z [M + Na]+ calcd for C33H33NNaO3: 514.2358; found: 514.2359.


#

4-Benzoyl-3a-benzyl-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4d)

White solid; yield: 161.5 mg (62%); mp 151–153 °C.

1H NMR (500 MHz, CDCl3): δ = 7.82 (d, J = 8.0 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.28–7.21 (m, 5 H), 7.17–7.13 (m, 5 H), 4.07 (d, J = 11.5 Hz, 1 H), 3.67 (td, J = 13.0, 6.0 Hz, 1 H), 3.37 (d, J = 13.5 Hz, 1 H), 3.11 (d, J = 8.0 Hz, 1 H), 2.90 (d, J = 13.5 Hz, 1 H), 2.64 (dd, J = 13.0, 6.0 Hz, 1 H), 2.17 (td, J = 13.5, 8.5 Hz, 1 H), 2.01 (d, J = 15.0 Hz, 1 H), 1.70 (s, 3 H), 1.68 (d, J = 9.0 Hz, 1 H), 1.63 (s, 3 H), 0.81 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.9, 180.0, 179.6, 140.1, 139.2, 136.0, 133.1, 130.7, 128.7, 128.2, 127.4, 127.1, 63.3, 63.0, 60.0, 50.1, 48.7, 47.5, 42.1, 35.7, 31.5, 30.9, 29.8, 29.1.

HRMS (ESI): m/z [M + Na]+ calcd for C35H39NNaO3: 544.2828; found: 544.2823.


#

4-Benzoyl-3a-benzyl-2-isopropyl-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4e)

White solid; yield: 83.4 mg (37%); mp 147–149 °C.

1H NMR (500 MHz, CDCl3): δ = 7.85 (d, J = 7.0 Hz, 2 H), 7.56 (t, J = 7.5 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.25–7.08 (m, 10 H), 4.32–4.26 (m, 1 H), 4.08 (d, J = 11.5 Hz, 1 H), 3.64–3.58 (m, 1 H), 3.44 (d, J = 13.0 Hz, 1 H), 3.11 (d, J = 8.5 Hz, 1 H), 2.89 (d, J = 13.5 Hz, 1 H), 2.60 (dd, J = 13.5, 6.0 Hz, 1 H), 2.21 (td, J = 13.0, 9.0 Hz, 1 H), 1.32 (d, J = 4.5 Hz, 3 H), 1.31 (d, J = 5.0 Hz, 3 H).

13C NMR (125 MHz, CDCl3): δ = 199.5, 178.5, 178.3, 139.9, 138.9, 135.9, 133.2, 130.1, 128.7, 128.68, 128.2, 127.5, 127.1, 127.1, 62.8, 60.1, 48.5, 47.6, 44.3, 42.2, 35.3, 19.3, 19.1.

HRMS (ESI): m/z [M + Na]+ calcd for C30H29NNaO3: 474.2045; found: 474.2037.


#

4-Benzoyl-2,3a-dibenzyl-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4f)

White solid; yield: 177.1 mg (71%); mp 172–174 °C.

1H NMR (500 MHz, CDCl3): δ = 7.87 (d, J = 7.0 Hz, 2 H), 7.57 (t, J = 7.5 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.26–7.14 (m, 11 H), 7.08 (t, J = 7.5 Hz, 2 H), 6.96 (d, J = 7.0 Hz, 2 H), 4.73 (d, J = 14.0 Hz, 1 H), 4.60 (d, J = 14.0 Hz, 1 H), 4.13 (d, J = 11.5 Hz, 1 H), 3.68–3.62 (m, 1 H), 3.46 (d, J = 13.5 Hz, 1 H), 3.21 (d, J = 8.5 Hz, 1 H), 2.92 (d, J = 13.5 Hz, 1 H), 2.63 (dd, J = 13.0, 6.0 Hz, 1 H), 2.25 (td, J = 13.0, 9.0 Hz, 1 H).

13C NMR (125 MHz, CDCl3): δ = 199.5, 178.2, 177.9, 139.7, 138.9, 135.5, 135.4, 133.3, 129.9, 128.7, 128.5, 128.3, 128.3, 127.6, 127.4, 127.2, 127.1, 63.0, 60.8, 48.7, 47.7, 42.9, 42.3, 35.2.

HRMS (ESI): m/z [M + Na]+ calcd for C34H29NNaO3: 522.2045; found: 522.2036.


#

2-(Adamantan-1-yl)-4-benzoyl-3a-benzyl-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4g)

Colorless oil; yield: 143.2 mg (55%).

1H NMR (500 MHz, CDCl3): δ = 7.84 (d, J = 7.0 Hz, 2 H), 7.54 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.29–7.10 (m, 10 H), 4.05 (d, J = 11.5 Hz, 1 H), 3.68–3.62 (m, 1 H), 3.41 (d, J = 13.0 Hz, 1 H), 3.00 (d, J = 8.5 Hz, 1 H), 2.86 (d, J = 13.5 Hz, 1 H), 2.56 (dd, J = 13.0, 6.0 Hz, 1 H), 2.35 (d, J = 3.0 Hz, 6 H), 2.19–2.14 (m, 1 H), 2.11 (s, 3 H), 1.75 (d, J = 11.5 Hz, 3 H), 1.65 (d, J = 12.5 Hz, 3 H).

13C NMR (125 MHz, CDCl3): δ = 199.8, 179.7, 179.6, 140.1, 139.1, 136.1, 133.1, 130.2, 128.7, 128.7, 128.6, 128.2, 127.4, 127.1, 127.0, 63.1, 61.7, 59.6, 48.5, 47.3, 42.4, 39.2, 36.2, 35.8, 29.8.

HRMS (ESI): m/z [M + H]+ calcd for C37H38NO3: 544.2852; found: 544.2841.


#

4-Benzoyl-3a-benzyl-2-(2,6-dimethylphenyl)-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4h)

White solid; yield: 59.0 mg (23%); mp 271–273 °C.

1H NMR (500 MHz, CDCl3): δ = 7.83 (dd, J = 9.0, 1.0 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.28–7.14 (m, 12 H), 6.97 (dd, J = 6.0, 3.0 Hz, 1 H), 4.18 (d, J = 11.5 Hz, 1 H), 3.95–3.89 (m, 1 H), 3.62 (d, J = 9.0 Hz, 1 H), 3.43 (d, J = 13.5 Hz, 1 H), 3.05 (d, J = 13.5 Hz, 1 H), 2.81 (dd, J = 13.0, 6.0 Hz, 1 H), 2.50 (s, 3 H), 2.41 (td, J = 13.5, 9.0 Hz, 1 H), 1.27 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 199.4, 177.4, 176.8, 139.6, 139.3, 136.5, 135.6, 135.4, 133.2, 130.9, 130.4, 129.3, 128.9, 128.8, 128.7, 128.6, 128.3, 128.2, 127.7, 127.3, 127.2, 63.4, 61.2, 48.8, 47.5, 42.7, 35.5, 18.7, 16.9.

HRMS (ESI): m/z [M + Na]+ calcd for C35H31NNaO3: 536.2202; found: 536.2194.


#

4-Benzoyl-3a-benzyl-2-(2-chloro-6-methylphenyl)-5-phenyltetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (4i)

White solid; yield: 109.3 mg (41%); mp 261–262 °C.

1H NMR (500 MHz, CDCl3): δ = 7.79 (d, J = 7.0 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.32–7.17 (m, 13 H), 4.20 (d, J = 11.5 Hz, 1 H), 3.88–3.82 (m, 1 H), 3.64 (d, J = 9.0 Hz, 1 H), 3.42 (d, J = 13.5 Hz, 1 H), 3.06 (d, J = 13.5 Hz, 1 H), 2.77 (dd, J = 13.0, 6.0 Hz, 1 H), 2.58 (s, 3 H), 2.29 (td, J = 13.5, 9.0 Hz, 1 H).

13C NMR (125 MHz, CDCl3): δ = 199.9, 176.9, 176.6, 139.5, 139.4, 139.2, 135.3, 133.3, 132.5, 131.0, 130.3, 129.5, 129.3, 128.8, 128.8, 128.7, 128.3, 127.6, 127.3, 127.1, 63.1, 61.1, 49.3, 48.1, 42.4, 35.3, 18.8.

HRMS (ESI): m/z [M + Na]+ calcd for C34H28ClNNaO3: 556.1655; found: 556.1658.


#

3a-Substituted 4-Benzoyl-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-diones 5; General Procedure

To a solution of 1,1,3,3-tetramethylbutyl isocyanide (1d, 0.5 mmol) and substituted allenoate 2 (0.6 mmol) in toluene–H2O (6:1, 5 mL), α,β-unsaturated ketone 3a (0.5 mmol) was added under a N2 atmosphere. The mixture was stirred under reflux for several hours (TLC monitoring). When the reaction was complete, the mixture was concentrated under vacuum. The residue was purified by column chromatography (silica gel 200–300, petroleum ether–EtOAc) to afford the product 5.


#

4-Benzoyl-3a-(3-fluorobenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5a)

White solid; yield: 164.4 mg (61%); mp 140–141 °C.

1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 8.0 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.25–7.15 (m, 6 H), 6.95–6.91 (m, 2 H), 6.84 (d, J = 9.5 Hz, 1 H), 4.03 (d, J = 11.5 Hz, 1 H), 3.70–3.64 (m, 1 H), 3.39 (d, J = 13.5 Hz, 1 H), 3.05 (d, J = 8.0 Hz, 1 H), 2.87 (d, J = 13.5 Hz, 1 H), 2.66 (dd, J = 13.0, 6.0 Hz, 1 H), 2.23 (td, J = 13.0, 8.0 Hz, 1 H), 2.04 (d, J = 15.0 Hz, 1 H), 1.68 (s, 3 H), 1.66–1.63 (m, 4 H), 0.79 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.7, 179.8, 179.3, 162.8 (d, 1 J C-F = 246.3 Hz), 139.9, 139.0, 138.4 (3 J C-F = 7.5 Hz), 133.2, 130.2 (d, 3 J C-F = 8.8 Hz), 128.7, 128.7, 128.1, 127.1, 127.0, 126.4 (d, 4 J C-F = 3.8 Hz), 117.7 (2 J C-F = 21.3 Hz), 114.4 (2 J C-F = 21.3 Hz), 63.5, 63.2, 59.9, 50.1, 48.5, 47.4, 41.8, 35.7, 31.4, 30.8, 29.8, 29.1.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38FNNaO3: 562.2733; found: 562.2729.


#

4-Benzoyl-3a-(4-chlorobenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5b)

White solid; yield: 127.7 mg (46%); mp 177–178 °C.

1H NMR (500 MHz, CDCl3): δ = 7.79 (d, J = 7.5 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.25–7.15 (m, 7 H), 7.06 (d, J = 8.5 Hz, 2 H), 4.02 (d, J = 11.5 Hz, 1 H), 3.69–3.63 (m, 1 H), 3.35 (d, J = 13.5 Hz, 1 H), 3.03 (d, J = 8.0 Hz, 1 H), 2.85 (d, J = 13.5 Hz, 1 H), 2.66 (dd, J = 13.0, 6.0 Hz, 1 H), 2.22 (td, J = 13.0, 8.0 Hz, 1 H), 2.02 (d, J = 15.0 Hz, 1 H), 1.67 (s, 3 H), 1.64–1.60 (m, 4 H), 0.77 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.7, 179.7, 179.3, 139.9, 139.0, 134.4, 133.4, 133.2, 132.1, 128.8, 128.7, 128.1, 127.2, 127.0, 63.5, 63.2, 59.9, 50.1, 48.5, 47.4, 41.4, 35.6, 31.4, 30.8, 29.8, 29.1.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38ClNNaO3: 578.2438; found: 578.2434.


#

4-Benzoyl-3a-(3-chlorobenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5c)

White solid; yield: 210.9 mg (76%); mp 125–127 °C.

1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 8.5 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.25–7.12 (m, 8 H), 7.02 (d, J = 7.0 Hz, 1 H), 4.03 (d, J = 11.5 Hz, 1 H), 3.70–3.64 (m, 1 H), 3.37 (d, J = 13.0 Hz, 1 H), 3.04 (d, J = 8.0 Hz, 1 H), 2.84 (d, J = 13.0 Hz, 1 H), 2.67 (dd, J = 13.0, 6.0 Hz, 1 H), 2.23 (td, J = 13.0, 8.0 Hz, 1 H), 2.05 (d, J = 15.0 Hz, 1 H), 1.69 (s, 3 H), 1.65–1.62 (m, 4 H), 0.80 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.6, 179.8, 179.2, 139.9, 139.0, 138.0, 134.5, 133.2, 130.8, 129.9, 128.8, 128.8, 128.7, 128.1, 127.6, 127.2, 127.0, 63.5, 63.2, 59.9, 50.1, 48.4, 47.4, 41.7, 35.7, 31.5, 30.9, 29.9, 29.0.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38ClNNaO3: 578.2438; found: 578.2439.


#

4-Benzoyl-3a-(4-bromobenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5d)

White solid; yield: 155.7 mg (52%); mp 187–188 °C.

1H NMR (500 MHz, CDCl3): δ = 7.78 (d, J = 7.0 Hz, 2 H), 7.55 (t, J = 7.0 Hz, 1 H), 7.44 (t, J = 7.0 Hz, 2 H), 7.36 (d, J = 8.5 Hz, 2 H), 7.25–7.14 (m, 5 H), 7.00 (d, J = 8.0 Hz, 2 H), 4.01 (d, J = 11.5 Hz, 1 H), 3.68–3.62 (m, 1 H), 3.33 (d, J = 13.5 Hz, 1 H), 3.03 (d, J = 8.0 Hz, 1 H), 2.83 (d, J = 13.5 Hz, 1 H), 2.66 (dd, J = 13.0, 6.0 Hz, 1 H), 2.22 (td, J = 13.0, 8.0 Hz, 1 H), 2.01 (d, J = 15.0 Hz, 1 H), 1.67 (s, 3 H), 1.63–1.60 (m, 4 H), 0.76 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.7, 179.7, 179.2, 139.9, 139.0, 134.9, 133.2, 132.4, 131.7, 128.7, 128.1, 127.2, 127.1, 121.5, 63.5, 63.2, 59.9, 50.1, 48.5, 47.4, 41.5, 35.6, 31.4, 30.8, 29.8, 29.1.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38BrNNaO3: 622.1933; found: 622.1928.


#

4-Benzoyl-3a-(4-nitrobenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5e)

White solid; yield: 101.9 mg (36%); mp 173–174 °C.

1H NMR (500 MHz, CDCl3): δ = 8.09 (d, J = 9.0 Hz, 2 H), 7.78 (d, J = 7.0 Hz, 2 H), 7.56 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.31 (d, J = 9.0 Hz, 2 H), 7.26–7.16 (m, 5 H), 4.03 (d, J = 11.5 Hz, 1 H), 3.70–3.63 (m, 1 H), 3.49 (d, J = 13.0 Hz, 1 H), 3.01–2.97 (m, 2 H), 2.70 (dd, J = 13.0, 6.0 Hz, 1 H), 2.29 (td, J = 13.0, 8.0 Hz, 1 H), 2.04 (d, J = 15.0 Hz, 1 H), 1.65 (s, 3 H), 1.64 (s, 3 H), 1.60–1.54 (m, 1 H), 0.71 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.4, 179.3, 178.9, 147.2, 143.5, 139.5, 138.9, 133.3, 131.8, 128.8, 128.8, 128.1, 127.3, 127.0, 123.7, 63.8, 63.4, 59.8, 50.0, 48.3, 47.4, 41.7, 35.6, 31.4, 30.8, 29.9, 28.9.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38N2NaO5: 589.2678; found: 589.2670.


#

4-Benzoyl-3a-(3-nitrobenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5f)

White solid; yield: 141.5 mg (50%); mp 141–142 °C.

1H NMR (500 MHz, CDCl3): δ = 8.08 (d, J = 8.5 Hz, 1 H), 8.02 (t, J = 1.8 Hz, 1 H), 7.79 (d, J = 7.5 Hz, 2 H), 7.56 (t, J = 7.5 Hz, 1 H), 7.49–7.40 (m, 4 H), 7.25–7.15 (m, 5 H), 4.05 (d, J = 11.5 Hz, 1 H), 3.70–3.63 (m, 1 H), 3.50 (d, J = 13.5 Hz, 1 H), 3.01–2.97 (m, 2 H), 2.69 (dd, J = 13.0, 6.0 Hz, 1 H), 2.30 (td, J = 13.0, 8.0 Hz, 1 H), 2.05 (d, J = 15.0 Hz, 1 H), 1.66 (s, 3 H), 1.65 (s, 3 H), 1.55 (d, J = 15.0 Hz, 1 H), 0.70 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.5, 179.4, 178.9, 148.3, 139.5, 138.9, 138.1, 137.0, 133.4, 129.6, 128.8, 128.8, 128.1, 127.3, 127.0, 125.6, 122.5, 63.7, 63.3, 59.8, 50.0, 48.2, 47.5, 41.5, 35.7, 31.4, 30.8, 30.0, 28.9.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38N2NaO5: 589.2678; found: 589.2675.


#

4-Benzoyl-3a-(4-methylbenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5g)

White solid; yield: 152.5 mg (57%); mp 197–198 °C.

1H NMR (500 MHz, CDCl3): δ = 7.81 (d, J = 7.0 Hz, 2 H), 7.54 (t, J = 7.5 Hz, 1 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.24–7.21 (m, 2 H), 7.16–7.13 (m, 3 H), 7.06 (d, J = 8.0 Hz, 2 H), 7.01 (d, J = 8.0 Hz, 2 H), 4.05 (d, J = 11.5 Hz, 1 H), 3.68–3.62 (m, 1 H), 3.31 (d, J = 13.5 Hz, 1 H), 3.09 (d, J = 8.0 Hz, 1 H), 2.85 (d, J = 13.5 Hz, 1 H), 2.62 (dd, J = 13.0, 6.0 Hz, 1 H), 2.30 (s, 3 H), 2.16 (td, J = 13.0, 8.0 Hz, 1 H), 1.98 (d, J = 15.0 Hz, 1 H), 1.68 (d, J = 15.0 Hz, 1 H), 1.67 (s, 3 H), 1.63 (s, 3 H), 0.80 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 200.0, 180.1, 179.6, 140.2, 139.2, 137.0, 133.1, 132.8, 130.5, 129.3, 128.7, 128.2, 127.1, 127.0, 63.2, 63.0, 60.0, 50.1, 48.8, 47.5, 41.6, 35.7, 31.4, 30.9, 29.7, 29.2, 21.0.

HRMS (ESI): m/z [M + Na]+ calcd for C36H41NNaO3: 558.2984; found: 558.2979.


#

4-Benzoyl-3a-(3-methylbenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5h)

White solid; yield: 163.2 mg (61%); mp 109–110 °C.

1H NMR (500 MHz, CDCl3): δ = 7.81 (d, J = 8.5 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.24–7.15 (m, 6 H), 7.05 (d, J = 7.5 Hz, 1 H), 6.94 (d, J = 7.5 Hz, 2 H), 4.06 (d, J = 11.5 Hz, 1 H), 3.69–3.63 (m, 1 H), 3.34 (d, J = 13.5 Hz, 1 H), 3.12 (d, J = 8.0 Hz, 1 H), 2.86 (d, J = 13.5 Hz, 1 H), 2.63 (dd, J = 13.0, 6.0 Hz, 1 H), 2.29 (s, 3 H), 2.17 (td, J = 13.0, 8.0 Hz, 1 H), 2.04 (d, J = 15.0 Hz, 1 H), 1.67 (d, J = 15.0 Hz, 1 H), 1.66 (s, 3 H), 1.63 (s, 3 H), 0.82 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.9, 180.1, 179.6, 140.2, 139.1, 138.2, 135.9, 133.1, 131.4, 128.7, 128.5, 128.1, 128.1, 127.7, 127.1, 63.3, 63.0, 60.0, 50.1, 48.7, 47.5, 42.0, 35.7, 31.5, 30.9, 29.8, 29.1, 21.4.

HRMS (ESI): m/z [M + Na]+ calcd for C36H41NNaO3: 558.2984; found: 558.2979.


#

4-Benzoyl-3a-(3-methoxybenzyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5i)

White solid; yield: 176.3 mg (64%); mp 213–214 °C.

1H NMR (500 MHz, CDCl3): δ = 7.81 (d, J = 7.0 Hz, 2 H), 7.54 (t, J = 7.5 Hz, 1 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.24–7.14 (m, 5 H), 7.05 (d, J = 9.0 Hz, 2 H), 6.79 (d, J = 9.0 Hz, 2 H), 4.05 (d, J = 11.5 Hz, 1 H), 3.76 (s, 3 H), 3.66 (m, 1 H), 3.31 (d, J = 13.5 Hz, 1 H), 3.09 (d, J = 8.0 Hz, 1 H), 2.83 (d, J = 13.5 Hz, 1 H), 2.63 (dd, J = 13.0, 6.0 Hz, 1 H), 2.18 (td, J = 13.0, 8.0 Hz, 1 H), 2.01 (d, J = 15.0 Hz, 1 H), 1.69 (s, 3 H), 1.68 (d, J = 15.0 Hz, 1 H), 1.64 (s, 3 H), 0.81 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 200.0, 180.1, 179.6, 158.9, 140.2, 139.2, 133.1, 131.7, 128.7, 128.1, 128.0, 127.1, 114.1, 63.2, 63.0, 60.1, 55.3, 50.1, 48.7, 47.5, 41.2, 35.6, 31.5, 30.9, 29.8, 29.2.

HRMS (ESI): m/z [M + Na]+ calcd for C36H41NNaO4: 574.2933; found: 574.2928.


#

4-Benzoyl-3a-methyl-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (5j)

Colorless oil; yield: 100.1 mg (45%).

1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 7.0 Hz, 2 H), 7.52 (t, J = 7.5 Hz, 1 H), 7.42 (t, J = 7.5 Hz, 2 H), 7.24–7.20 (m, 4 H), 7.16–7.13 (m, 1 H), 3.89 (d, J = 11.5 Hz, 1 H), 3.70–3.64 (m, 1 H), 2.78 (d, J = 8.5 Hz, 1 H), 2.65 (dd, J = 13.0, 6.0 Hz, 1 H), 2.31 (td, J = 13.0, 8.5 Hz, 1 H), 2.00 (d, J = 15.0 Hz, 1 H), 1.87 (d, J = 15.0 Hz, 1 H), 1.77 (s, 3 H), 1.71 (s, 3 H), 1.49 (s, 3 H), 0.97 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.4, 180.8, 179.9, 140.0, 138.7, 133.1, 128.6, 128.6, 128.2, 127.1, 127.0, 63.9, 62.8, 54.0, 53.0, 50.0, 47.4, 35.9, 31.8, 31.1, 29.9, 29.3, 23.8.

HRMS (ESI): m/z [M + H]+ calcd for C29H36NO3: 446.2695; found: 446.2689.


#

Methyl [4-Benzoyl-1,3-dioxo-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)octahydrocyclopenta[c]pyrrol-3a-yl]acetate (5k)

White solid; yield: 118.2 mg (47%); mp 114–115 °C.

1H NMR (500 MHz, CDCl3): δ = 7.78 (d, J = 7.5 Hz, 2 H), 7.53 (t, J = 7.5 Hz, 1 H), 7.41 (t, J = 7.5 Hz, 2 H), 7.23–7.13 (m, 5 H), 4.26 (d, J = 11.5 Hz, 1 H), 3.71 (s, 3 H), 3.69–3.63 (m, 1 H), 3.10 (d, J = 8.5 Hz, 1 H), 2.83 (d, J = 16.5 Hz, 1 H), 2.76 (d, J = 16.5 Hz, 1 H), 2.63 (dd, J = 13.0, 6.0 Hz, 1 H), 2.36 (td, J = 13.0, 8.5 Hz, 1 H), 2.03 (d, J = 15.0 Hz, 1 H), 1.89 (d, J = 15.0 Hz, 1 H), 1.77 (s, 3 H), 1.73 (s, 3 H), 1.00 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.2, 179.7, 179.3, 171.0, 139.9, 138.8, 133.3, 128.7, 128.7, 128.1, 127.2, 127.1, 63.3, 60.6, 55.4, 52.1, 50.7, 50.2, 46.8, 39.3, 36.6, 31.6, 31.2, 29.7, 28.9.

HRMS (ESI): m/z [M + H]+ calcd for C31H38NO5: 504.2750; found: 504.2743.


#

Ethyl [4-Benzoyl-1,3-dioxo-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)octahydrocyclopenta[c]pyrrol-3a-yl]acetate (5l)

White solid; yield: 131.8 mg (51%); mp 107–109 °C.

1H NMR (500 MHz, CDCl3): δ = 7.79 (d, J = 7.5 Hz, 2 H), 7.53 (t, J = 7.5 Hz, 1 H), 7.42 (t, J = 7.5 Hz, 2 H), 7.23–7.21 (m, 4 H), 7.17–7.13 (m, 1 H), 4.29 (d, J = 11.5 Hz, 1 H), 4.24–4.14 (m, 2 H), 3.69–3.63 (m, 1 H), 3.13 (d, J = 8.5 Hz, 1 H), 2.82 (d, J = 16.5 Hz, 1 H), 2.73 (d, J = 16.5 Hz, 1 H), 2.63 (dd, J = 13.0, 6.0 Hz, 1 H), 2.37 (td, J = 13.0, 8.5 Hz, 1 H), 2.03 (d, J = 15.0 Hz, 1 H), 1.89 (d, J = 15.0 Hz, 1 H), 1.77 (s, 3 H), 1.73 (s, 3 H), 1.29 (t, J = 7.0 Hz, 3 H), 1.00 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.2, 179.7, 179.3, 170.6, 140.0, 138.8, 133.2, 128.7, 128.7, 128.1, 127.2, 127.1, 63.3, 61.2, 60.4, 55.4, 50.7, 50.2, 46.8, 39.4, 36.6, 31.6, 31.2, 29.7, 29.0, 14.2.

HRMS (ESI): m/z [M + Na]+ calcd for C32H39NNaO5: 540.2726; found: 540.2729.


#

4-Aroyl-5-aryl-3a-benzyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-diones 6; General Procedure

To a solution of 1,1,3,3-tetramethylbutyl isocyanide (1d, 0.5 mmol) and substituted allenoate 2a (0.6 mmol) in toluene–H2O (6:1, 5 mL), α,β-unsaturated ketone 3 (0.5 mmol) was added under a N2 atmosphere. The mixture was stirred under reflux for several hours (TLC monitoring). When the reaction was complete, the mixture was concentrated under vacuum. The residue was purified by column chromatography (silica gel 200–300, petroleum ether–EtOAc) to afford the product 6.


#

3a-Benzyl-4-(4-fluorobenzoyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6a)

White solid; yield: 142.8 mg (53%); mp 148–149 °C.

1H NMR (500 MHz, CDCl3): δ = 7.85–7.81 (m, 2 H), 7.29–7.21 (m, 5 H), 7.17–7.09 (m, 7 H), 4.00 (d, J = 11.0 Hz, 1 H), 3.68–3.62 (m, 1 H), 3.37 (d, J = 13.5 Hz, 1 H), 3.11 (d, J = 8.0 Hz, 1 H), 2.89 (d, J = 13.5 Hz, 1 H), 2.64 (dd, J = 13.0, 6.0 Hz, 1 H), 2.22–2.15 (m, 1 H), 2.01 (d, J = 15.0 Hz, 1 H), 1.69 (s, 3 H), 1.68 (d, J = 15.0 Hz, 1 H), 1.62 (s, 3 H), 0.80 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 198.3, 179.9, 179.5, 165.8 (d, 1 J C-F = 252.5 Hz), 140.0, 135.9, 135.5 (d, 4 J C-F = 2.5 Hz), 130.7 (d, 3 J C-F = 8.8 Hz), 130.7, 128.7, 127.5, 127.1 (d, 2 J C-F = 17.5 Hz), 115.8 (d, 2 J C-F = 22.5 Hz), 63.4, 63.1, 60.0, 50.1, 48.7, 47.6, 42.1, 35.6, 31.5, 30.9, 29.8, 29.1.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38FNNaO3: 562.2733; found: 562.2727.


#

3a-Benzyl-4-(4-chlorobenzoyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6b)

Colorless oil; yield: 169.3 mg (61%).

1H NMR (500 MHz, CDCl3): δ = 7.73 (d, J = 8.5 Hz, 2 H), 7.41 (d, J = 8.5 Hz, 2 H), 7.27–7.21 (m, 5 H), 7.17–7.11 (m, 5 H), 3.97 (d, J = 11.5 Hz, 1 H), 3.66–3.59 (m, 1 H), 3.34 (d, J = 13.5 Hz, 1 H), 3.10 (d, J = 8.0 Hz, 1 H), 2.88 (d, J = 13.5 Hz, 1 H), 2.62 (dd, J = 13.0, 6.0 Hz, 1 H), 2.17 (td, J = 13.0, 8.0 Hz, 1 H), 1.99 (d, J = 15.0 Hz, 1 H), 1.66–1.63 (m, 4 H), 1.60 (s, 3 H), 0.79 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 198.8, 179.9, 179.5, 139.9, 139.6, 137.4, 135.8, 130.7, 129.5, 129.0, 128.7, 127.5, 127.2, 127.0, 63.4, 63.1, 60.0, 50.1, 48.7, 47.6, 42.1, 35.6, 31.4, 30.9, 29.7, 29.1.

HRMS (ESI): m/z [M + H]+ calcd for C35H39ClNO3: 556.2618; found: 556.2617.


#

3a-Benzyl-4-(3-chlorobenzoyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6c)

White solid; yield: 160.9 mg (58%); mp 126–127 °C.

1H NMR (500 MHz, CDCl3): δ = 7.76 (t, J = 1.8 Hz, 1 H), 7.66 (d, J = 8.0 Hz, 1 H), 7.51 (d, J = 9.0 Hz, 1 H), 7.38 (t, J = 8.0 Hz, 1 H), 7.30–7.22 (m, 5 H), 7.18–7.12 (m, 5 H), 3.97 (d, J = 12.0 Hz, 1 H), 3.65–3.59 (m, 1 H), 3.36 (d, J = 13.5 Hz, 1 H), 3.12 (d, J = 8.0 Hz, 1 H), 2.91 (d, J = 13.5 Hz, 1 H), 2.62 (dd, J = 13.0, 6.0 Hz, 1 H), 2.18 (td, J = 13.5, 8.0 Hz, 1 H), 1.99 (d, J = 15.0 Hz, 1 H), 1.70–1.67 (m, 4 H), 1.61 (s, 3 H), 0.81 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 198.8, 179.9, 179.5, 140.6, 139.8, 135.8, 135.0, 133.0, 130.7, 130.0, 128.8, 128.3, 127.5, 127.2, 127.0, 126.2, 63.4, 63.1, 60.1, 50.1, 48.8, 47.6, 42.09, 35.7, 31.5, 30.9, 29.7, 29.1.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38ClNNaO3: 578.2438; found: 578.2437.


#

3a-Benzyl-4-(4-bromobenzoyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6d)

White solid; yield: 167.7 mg (56%); mp 161–162 °C.

1H NMR (500 MHz, CDCl3): δ = 7.65 (d, J = 9.0 Hz, 2 H), 7.58 (d, J = 8.5 Hz, 2 H), 7.28–7.21 (m, 5 H), 7.17–7.10 (m, 5 H), 3.95 (d, J = 11.5 Hz, 1 H), 3.65–3.58 (m, 1 H), 3.33 (d, J = 13.5 Hz, 1 H), 3.10 (d, J = 8.0 Hz, 1 H), 2.87 (d, J = 13.5 Hz, 1 H), 2.62 (dd, J = 13.0, 6.0 Hz, 1 H), 2.15 (td, J = 13.0, 8.5 Hz, 1 H), 1.98 (d, J = 15.0 Hz, 1 H), 1.66 (d, J = 15.0 Hz, 1 H), 1.65 (s, 3 H), 1.59 (s, 3 H), 0.79 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.0, 179.9, 179.5, 139.9, 137.8, 135.8, 132.0, 130.7, 129.6, 128.7, 128.4, 127.5, 127.2, 127.9, 63.4, 63.1, 60.1, 50.1, 48.7, 47.5, 42.1, 35.6, 31.5, 30.9, 29.7, 29.1.

HRMS (ESI): m/z [M + Na]+ calcd for C35H38BrNNaO3: 622.1933; found: 622.1926.


#

3a-Benzyl-4-(4-methylbenzoyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6e)

White solid; yield: 173.9 mg (65%); mp 139–140 °C.

1H NMR (500 MHz, CDCl3): δ = 7.73 (d, J = 8.5 Hz, 2 H), 7.28–7.20 (m, 7 H), 7.15–7.13 (m, 5 H), 4.03 (d, J = 11.5 Hz, 1 H), 3.69–3.63 (m, 1 H), 3.39 (d, J = 13.5 Hz, 1 H), 3.09 (d, J = 8.0 Hz, 1 H), 2.88 (d, J = 13.5 Hz, 1 H), 2.63 (dd, J = 13.0, 6.0 Hz, 1 H), 2.39 (s, 3 H), 2.15 (td, J = 13.0, 8.0 Hz, 1 H), 2.00 (d, J = 15.0 Hz, 1 H), 1.67–1.64 (m, 4 H), 1.62 (s, 3 H), 0.78 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.2, 180.1, 179.5, 144.0, 140.2, 136.6, 136.1, 130.7, 129.4, 128.7, 128.6, 128.3, 127.4, 127.1, 127.0, 63.10, 63.0, 59.9, 50.1, 48.7, 47.4, 42.0, 35.6, 31.4, 30.9, 29.8, 29.1, 21.6.

HRMS (ESI): m/z [M + H]+ calcd for C36H42NO3: 536.3165; found: 536.3156.


#

3a-Benzyl-4-(4-methoxybenzoyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6f)

White solid; yield: 104.7 mg (38%); mp 145–146 °C.

1H NMR (500 MHz, CDCl3): δ = 7.83 (d, J = 9.0 Hz, 2 H), 7.28–7.19 (m, 5 H), 7.15–7.12 (m, 5 H), 6.92 (d, J = 9.0 Hz, 2 H), 4.00 (d, J = 11.5 Hz, 1 H), 3.84 (s, 3 H), 3.68–3.62 (m, 1 H), 3.42 (d, J = 13.5 Hz, 1 H), 3.08 (d, J = 8.0 Hz, 1 H), 2.89 (d, J = 13.5 Hz, 1 H), 2.63 (dd, J = 13.0, 6.0 Hz, 1 H), 2.16 (td, J = 13.0, 8.0 Hz, 1 H), 2.01 (d, J = 15.0 Hz, 1 H), 1.67 (s, 3 H), 1.65–1.62 (m, 4 H), 0.77 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 197.8, 180.1, 179.5, 163.7, 140.3, 136.1, 132.0, 130.7, 130.5, 128.7, 128.6, 127.3, 127.0, 127.0, 113.9, 63.0, 59.8, 55.5, 50.1, 48.7, 47.5, 42.1, 35.6, 31.4, 30.9, 29.8, 29.0.

HRMS (ESI): m/z [M + Na]+ calcd for C36H41NNaO4: 574.2933; found: 574.2929.


#

3a-Benzyl-4-(1-naphthoyl)-5-phenyl-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6g)

White solid; yield: 114.2 mg (40%); mp 172–173 °C.

1H NMR (500 MHz, CDCl3): δ = 8.12 (d, J = 8.5 Hz, 1 H), 7.94 (d, J = 8.0 Hz, 1 H), 7.84 (d, J = 7.5 Hz, 1 H), 7.53–7.47 (m, 3 H), 7.41 (t, J = 7.5 Hz, 1 H), 7.29–7.16 (m, 8 H), 6.97 (d, J = 7.5 Hz, 2 H), 4.05 (d, J = 11.5 Hz, 1 H), 3.70–3.64 (m, 1 H), 3.12 (d, J = 11.5 Hz, 2 H), 2.79 (d, J = 13.5 Hz, 1 H), 2.59 (dd, J = 13.0, 6.0 Hz, 1 H), 2.13–2.07 (m, 2 H), 1.83–1.79 (m, 4 H), 1.78 (s, 3 H), 0.90 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 203.3, 180.1, 180.1, 139.9, 138.1, 135.9, 133.9, 132.6, 130.6, 130.2, 128.8, 128.6, 128.2, 127.7, 127.5, 127.3, 127.3, 127.1, 126.5, 126.2, 124.2, 66.2, 63.2, 59.9, 50.2, 49.2, 47.8, 41.7, 35.2, 31.6, 31.1, 29.9, 29.5.

HRMS (ESI): m/z [M + Na]+ calcd for C39H41NNaO3: 594.2984; found: 594.2978.


#

4-Benzoyl-3a-benzyl-5-(4-chlorophenyl)-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6h)

Colorless oil; yield: 133.2 mg (48%).

1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 7.5 Hz, 2 H), 7.56 (t, J = 7.5 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.28–7.06 (m, 9 H), 3.99 (d, J = 11.5 Hz, 1 H), 3.65–3.59 (m, 1 H), 3.35 (d, J = 13.5 Hz, 1 H), 3.10 (d, J = 8.0 Hz, 1 H), 2.88 (d, J = 13.5 Hz, 1 H), 2.60 (dd, J = 13.0, 6.0 Hz, 1 H), 2.11 (td, J = 13.0, 8.0 Hz, 1 H), 1.98 (d, J = 15.0 Hz, 1 H), 1.69–1.66 (m, 4 H), 1.60 (s, 3 H), 0.80 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.7, 179.8, 179.4, 139.0, 138.6, 135.9, 133.3, 132.8, 130.7, 128.8, 128.8, 128.7, 128.4, 128.1, 127.5, 63.2, 63.1, 59.9, 50.1, 48.7, 46.8, 42.0, 35.5, 31.5, 30.9, 29.7, 29.1.

HRMS (ESI): m/z [M + H]+ calcd for C35H39ClNO3: 556.2618; found: 556.2614.


#

4-Benzoyl-3a-benzyl-5-(4-bromophenyl)-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6i)

Colorless oil; yield: 152.7 mg (51%).

1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 7.0 Hz, 2 H), 7.57 (t, J = 7.5 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.34 (d, J = 8.5 Hz, 2 H), 7.28–7.23 (m, 3 H), 7.12 (dd, J = 7.5, 1.5 Hz, 2 H), 7.01 (d, J = 8.5 Hz, 2 H), 3.98 (d, J = 11.5 Hz, 1 H), 3.64–3.58 (m, 1 H), 3.35 (d, J = 13.5 Hz, 1 H), 3.10 (d, J = 8.0 Hz, 1 H), 2.88 (d, J = 13.5 Hz, 1 H), 2.59 (dd, J = 13.0, 6.0 Hz, 1 H), 2.10 (td, J = 13.0, 8.0 Hz, 1 H), 1.98 (d, J = 15.0 Hz, 1 H), 1.69–1.66 (m, 4 H), 1.60 (s, 3 H), 0.80 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.7, 179.8, 179.4, 139.1, 139.0, 135.9, 133.3, 131.8, 130.7, 128.8, 128.8, 128.7, 128.1, 127.5, 120.9, 63.2, 63.1, 59.9, 50.1, 48.7, 46.8, 43.9, 42.0, 36.1, 35.5, 32.9, 31.5, 31.2, 30.9, 30.0, 29.7, 29.4, 29.1.

HRMS (ESI): m/z [M + H]+ calcd for C35H39BrNO3: 600.2113; found: 600.2101.


#

4-Benzoyl-3a-benzyl-5-(p-tolyl)-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6j)

White solid; yield: 133.8 mg (50%); mp 134–135 °C.

1H NMR (500 MHz, CDCl3): δ = 7.81 (d, J = 7.0 Hz, 2 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.27–7.21 (m, 3 H), 7.12 (d, J = 6.0 Hz, 2 H), 7.03 (s, 4 H), 4.03 (d, J = 11.5 Hz, 1 H), 3.64–3.58 (m, 1 H), 3.35 (d, J = 13.5 Hz, 1 H), 3.08 (d, J = 8.0 Hz, 1 H), 2.88 (d, J = 13.5 Hz, 1 H), 2.59 (dd, J = 13.0, 6.0 Hz, 1 H), 2.25 (s, 3 H), 2.13 (td, J = 13.0, 8.0 Hz, 1 H), 1.99 (d, J = 15.0 Hz, 1 H), 1.67 (s, 3 H), 1.66 (d, J = 15.0 Hz, 1 H), 1.61 (s, 3 H), 0.79 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 200.0, 180.1, 179.6, 139.2, 137.0, 136.6, 136.0, 133.0, 130.7, 129.3, 128.7, 128.2, 127.4, 126.9, 63.3, 63.0, 59.9, 50.1, 48.7, 47.1, 42.1, 35.8, 31.4, 30.9, 29.8, 29.1, 21.0.

HRMS (ESI): m/z [M + H]+ calcd for C36H42NO3: 536.3165; found: 536.3156.


#

4-Benzoyl-3a-benzyl-5-(4-methoxyphenyl)-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6k)

White solid; yield: 154.3 mg (56%); mp 92–93 °C.

1H NMR (500 MHz, CDCl3): δ = 7.80 (d, J = 7.5 Hz, 2 H), 7.54 (t, J = 7.5 Hz, 1 H), 7.44 (t, J = 7.5 Hz, 2 H), 7.28–7.21 (m, 3 H), 7.13 (d, J = 6.0 Hz, 2 H), 7.06 (d, J = 8.5 Hz, 2 H), 6.75 (d, J = 8.5 Hz, 2 H), 4.00 (d, J = 11.5 Hz, 1 H), 3.72 (s, 3 H), 3.63–3.57 (m, 1 H), 3.34 (d, J = 13.5 Hz, 1 H), 3.09 (d, J = 8.0 Hz, 1 H), 2.88 (d, J = 13.5 Hz, 1 H), 2.59 (dd, J = 13.0, 6.0 Hz, 1 H), 2.12 (td, J = 13.0, 8.0 Hz, 1 H), 2.00 (d, J = 15.0 Hz, 1 H), 1.67 (s, 3 H), 1.66 (d, J = 15.0 Hz, 1 H), 1.62 (s, 3 H), 0.79 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 200.1, 180.1, 179.6, 158.5, 139.2, 136.0, 133.1, 132.1, 130.7, 128.7, 128.1, 128.0, 127.4, 114.1, 63.5, 63.0, 59.9, 55.2, 50.1, 48.7, 46.8, 42.1, 35.7, 31.5, 30.9, 29.8, 29.1.

HRMS (ESI): m/z [M + H]+ calcd for C36H42NO4: 552.3114; found: 552.3109.


#

4-Benzoyl-3a-benzyl-5-[(E)-styryl]-2-(2,4,4-trimethylpentan-2-yl)tetrahydrocyclopenta[c]pyrrole-1,3(2H,3aH)-dione (6l)

White solid; yield: 134.0 mg (49%); mp 147–148 °C.

1H NMR (500 MHz, CDCl3): δ = 7.97 (d, J = 7.0 Hz, 2 H), 7.60 (t, J = 7.5 Hz, 1 H), 7.51 (t, J = 7.5 Hz, 2 H), 7.25–7.17 (m, 8 H), 7.10 (d, J = 6.0 Hz, 2 H), 6.41 (d, J = 16.0 Hz, 1 H), 6.01 (dd, J = 16.0, 7.5 Hz, 1 H), 3.81 (d, J = 11.5 Hz, 1 H), 3.42 (d, J = 13.5 Hz, 1 H), 3.32–3.27 (m, 1 H), 3.04 (d, J = 8.0 Hz, 1 H), 2.84 (d, J = 13.5 Hz, 1 H), 2.54 (dd, J = 13.0, 6.0 Hz, 1 H), 2.02–1.95 (m, 2 H), 1.65–1.62 (m, 4 H), 1.60 (s, 3 H), 0.77 (s, 9 H).

13C NMR (125 MHz, CDCl3): δ = 199.6, 180.0, 179.4, 139.0, 136.8, 136.0, 133.3, 131.6, 130.7, 128.8, 128.7, 128.5, 128.3, 127.5, 127.3, 126.2, 63.0, 62.0, 60.1, 50.1, 48.4, 45.4, 42.2, 34.5, 31.4, 30.9, 29.7, 29.1.

HRMS (ESI): m/z [M + H]+ calcd for C37H42NO3: 548.3165; found: 548.3165.


#

3a-Substituted 5-Aroyl-2-(2,6-dimethylphenyl)-1′-methyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-triones 8 or Ethyl 5-Benzoyl-2-[(2,6-diisopropylphenyl)carbamoyl]-1′,2-dimethyl-2′-oxospiro[cyclopentane-1,3′-indoline]-3-carboxylates 9; General Procedure

To a solution of isocyanide 1 (0.5 mmol) and substituted allenoate 2 (0.6 mmol) in toluene–H2O (6:1, 5 mL), methyleneindolinone 7 (0.5 mmol) was added under a N2 atmosphere. The mixture was stirred and heated under reflux for several hours (TLC monitoring). When the reaction was complete, the mixture was concentrated under vacuum. The residue was purified by column chromatography (silica gel 200–300, petroleum ether–EtOAc) to afford the desired product 8 or 9.


#

5-Benzoyl-2-(2,6-dimethylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8a)

White solid; yield: 86.1 mg (35%); mp 300–302 °C.

1H NMR (500 MHz, CDCl3): δ = 7.79 (d, J = 7.5 Hz, 2 H), 7.53 (t, J = 7.5 Hz, 1 H), 7.41 (t, J = 7.5 Hz, 2 H), 7.28 (t, J = 7.5 Hz, 1 H), 7.21–7.14 (m, 3 H), 7.06 (d, J = 7.0 Hz, 1 H), 6.98 (t, J = 7.5 Hz, 1 H), 6.85 (d, J = 8.0 Hz, 1 H), 4.51 (dd, J = 13.5, 6.5 Hz, 1 H), 3.41 (t, J = 9.5 Hz, 1 H), 3.25–3.17 (m, 4 H), 2.87–2.81 (m, 1 H), 2.42 (s, 3 H), 2.05 (s, 3 H), 1.61 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 196.1, 178.5, 178.4, 175.5, 145.5, 138.0, 135.9, 135.4, 133.7, 130.2, 129.5, 129.3, 129.2, 128.8, 128.4, 128.3, 126.9, 124.5, 121.7, 108.9, 60.0, 58.8, 56.3, 53.4, 30.5, 26.5, 25.4, 18.3, 18.1.

HRMS (ESI): m/z [M + H]+ calcd for C31H28N2O4: 493.2127; found: 493.2129.


#

5-(4-Chlorobenzoyl)-2-(2,6-dimethylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8b)

White solid; yield: 110.5 mg (42%); mp 314–315 °C.

1H NMR (500 MHz, CDCl3): δ = 7.72 (d, J = 8.5 Hz, 2 H), 7.37 (d, J = 8.5 Hz, 2 H), 7.29 (td, J = 7.5, 0.5 Hz, 1 H), 7.22–7.12 (m, 3 H), 7.06 (d, J = 7.0 Hz, 1 H), 6.99 (t, J = 7.5 Hz, 1 H), 6.85 (d, J = 8.0 Hz, 1 H), 4.45 (dd, J = 13.5, 6.5 Hz, 1 H), 3.39 (t, J = 9.5 Hz, 1 H), 3.26–3.15 (m, 4 H), 2.83–2.77 (m, 1 H), 2.42 (s, 3 H), 2.05 (s, 3 H), 1.60 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 195.0, 178.4, 178.2, 175.4, 145.5, 140.2, 137.9, 135.3, 134.2, 130.1, 129.8, 129.5, 129.4, 129.2, 129.1, 128.3, 126.7, 124.5, 121.7, 108.9, 59.8, 58.8, 56.2, 53.3, 30.4, 26.4, 25.4, 18.2, 18.1.

HRMS (ESI): m/z [M + H]+ calcd for C31H28ClN2O4: 527.1738; found: 527.1731.


#

5-(3-Chlorobenzoyl)-2-(2,6-dimethylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8c)

White solid; yield: 94.7 mg (36%); mp 292–293 °C.

1H NMR (500 MHz, CDCl3): δ = 7.73 (s, 1 H), 7.65 (d, J = 7.5 Hz, 1 H), 7.50 (d, J = 8.5 Hz, 1 H), 7.35 (t, J = 8.0 Hz, 1 H), 7.29 (t, J = 8.0 Hz, 1 H), 7.20 (t, J = 7.5 Hz, 2 H), 7.15 (d, J = 7.0 Hz, 1 H), 7.06 (d, J = 7.0 Hz, 1 H), 7.00 (t, J = 7.5 Hz, 1 H), 6.85 (d, J = 7.5 Hz, 1 H), 4.42 (dd, J = 13.5, 6.5 Hz, 1 H), 3.41 (t, J = 9.5 Hz, 1 H), 3.25–3.17 (m, 4 H), 2.85–2.80 (m, 1 H), 2.41 (s, 3 H), 2.05 (s, 3 H), 1.62 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 195.1, 178.4, 178.1, 175.4, 145.5, 137.9, 137.5, 135.3, 135.2, 133.6, 130.2, 129.5, 129.4, 129.3, 128.5, 128.3, 126.7, 126.5, 124.6, 121.8, 109.0, 59.9, 58.9, 56.3, 53.3, 30.3, 26.5, 25.4, 18.2, 18.1.

HRMS (ESI): m/z [M + Na]+ calcd for C31H27ClN2NaO4: 549.1557; found: 549.1551.


#

5-(4-Bromobenzoyl)-2-(2,6-dimethylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8d)

White solid; yield: 148.2 mg (52%); mp 296–297 °C.

1H NMR (500 MHz, CDCl3): δ = 7.64 (d, J = 8.5 Hz, 2 H), 7.54 (d, J = 8.5 Hz, 2 H), 7.29 (t, J = 7.5 Hz, 1 H), 7.21–7.14 (m, 3 H), 7.06 (d, J = 7.0 Hz, 1 H), 6.99 (t, J = 7.5 Hz, 1 H), 6.85 (d, J = 7.5 Hz, 1 H), 4.43 (dd, J = 13.5, 6.5 Hz, 1 H), 3.40 (t, J = 9.5 Hz, 1 H), 3.24–3.16 (m, 4 H), 2.83–2.77 (m, 1 H), 2.41 (s, 3 H), 2.05 (s, 3 H), 1.60 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 195.2, 178.4, 178.2, 175.4, 145.5, 137.9, 135.3, 134.6, 132.1, 130.1, 129.9, 129.5, 129.4, 129.3, 128.9, 128.3, 126.7, 124.5, 121.8, 109.0, 59.8, 58.8, 56.3, 53.4, 30.4, 26.4, 25.4, 18.2, 18.1.

HRMS (ESI): m/z [M + Na]+ calcd for C31H27BrN2NaO4: 593.1052; found: 593.1056.


#

2-(2,6-Dimethylphenyl)-1′,3a-dimethyl-5-(4-nitrobenzoyl)-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8e)

White solid; yield: 56.4 mg (21%); mp 293–294 °C.

1H NMR (500 MHz, DMSO-d 6): δ = 8.28 (d, J = 8.5 Hz, 2 H), 8.10 (d, J = 9.0 Hz, 2 H), 7.49 (d, J = 7.5 Hz, 1 H), 7.27 (t, J = 7.5 Hz, 1 H), 7.22 (t, J = 7.5 Hz, 1 H), 7.15 (d, J = 7.5 Hz, 1 H), 7.11 (d, J = 7.5 Hz, 1 H), 7.03–6.95 (m, 2 H), 5.21 (dd, J = 12.5, 7.0 Hz, 1 H), 3.71 (t, J = 9.5 Hz, 1 H), 3.07 (s, 3 H), 2.81–2.65 (m, 2 H), 2.25 (s, 3 H), 1.99 (s, 3 H), 1.58 (s, 3 H).

13C NMR (125 MHz, DMSO-d 6): δ = 197.0, 178.1, 177.5, 175.8, 150.1, 144.7, 140.3, 137.2, 135.5, 130.5, 129.7, 128.9, 128.8, 128.5, 128.0, 126.8, 125.4, 123.8, 121.5, 108.5, 58.9, 58.4, 55.9, 51.7, 29.0, 26.0, 23.8, 17.7, 17.5.

HRMS (ESI): m/z [M + Na]+ calcd for C31H27N3NaO6: 560.1798; found: 560.1794.


#

2-(2,6-Dimethylphenyl)-1′,3a-dimethyl-5-(4-methylbenzoyl)-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8f)

White solid; yield: 113.9 mg (45%); mp 254–255 °C.

1H NMR (500 MHz, CDCl3): δ = 7.70 (d, J = 8.0 Hz, 2 H), 7.29–7.14 (m, 6 H), 7.06 (d, J = 7.0 Hz, 1 H), 6.97 (t, J = 7.5 Hz, 1 H), 6.85 (d, J = 7.5 Hz, 1 H), 4.49 (dd, J = 13.5, 6.5 Hz, 1 H), 3.40 (t, J = 9.5 Hz, 1 H), 3.23–3.16 (m, 4 H), 2.86–2.81 (m, 1 H), 2.42 (s, 3 H), 2.38 (s, 3 H), 2.05 (s, 3 H), 1.60 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 195.6, 178.5, 175.6, 145.5, 144.6, 138.0, 135.3, 133.4, 130.2, 129.5, 129.4, 129.3, 129.2, 128.6, 128.2, 126.9, 124.5, 121.6, 108.9, 59.9, 58.8, 56.2, 53.5, 30.6, 26.4, 25.4, 21.8, 18.3, 18.1.

HRMS (ESI): m/z [M + Na]+ calcd for C32H30N2NaO4: 529.2103; found: 529.2091.


#

2-(2,6-Dimethylphenyl)-5-(4-methoxybenzoyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8g)

White solid; yield: 143.6 mg (55%); mp 235–236 °C.

1H NMR (500 MHz, DMSO-d 6): δ = 7.94 (d, J = 9.0 Hz, 2 H), 7.44 (d, J = 7.5 Hz, 1 H), 7.27 (t, J = 7.5 Hz, 1 H), 7.22 (t, J = 7.5 Hz, 1 H), 7.15 (d, J = 7.5 Hz, 1 H), 7.11 (d, J = 7.5 Hz, 1 H), 7.03–6.97 (m, 4 H), 5.07 (dd, J = 13.0, 7.0 Hz, 1 H), 3.83 (s, 3 H), 3.70 (t, J = 9.0 Hz, 1 H), 3.08 (s, 3 H), 2.81–2.74 (m, 1 H), 2.69–2.63 (m, 1 H), 2.27 (s, 3 H), 1.99 (s, 3 H), 1.58 (s, 3 H).

13C NMR (125 MHz, DMSO-d 6): δ = 195.2, 178.2, 178.0, 175.8, 163.5, 144.94 137.2, 135.5, 130.8, 130.6, 128.9, 128.5, 128.3, 127.9, 127.2, 125.1, 121.2, 114.0, 108.3, 58.4, 58.3, 55.6, 55.6, 51.9, 29.6, 26.0, 23.7, 17.7, 17.5.

HRMS (ESI): m/z [M + Na]+ calcd for C32H30N2NaO5: 545.2052; found: 545.2041.


#

5-(Biphenyl-4-ylcarbonyl)-2-(2,6-dimethylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8h)

White solid; yield: 107.9 mg (38%); mp 239–240 °C.

1H NMR (500 MHz, CDCl3): δ = 7.87 (d, J = 8.5 Hz, 2 H), 7.62 (d, J = 8.5 Hz, 2 H), 7.59 (d, J = 7.5 Hz, 2 H), 7.47 (t, J = 7.5 Hz, 2 H), 7.40 (t, J = 7.5 Hz, 1 H), 7.29 (t, J = 7.5 Hz, 1 H), 7.21–7.16 (m, 3 H), 7.07 (d, J = 7.0 Hz, 1 H), 6.99 (t, J = 7.5 Hz, 1 H), 6.86 (d, J = 8.0 Hz, 1 H), 4.55 (dd, J = 13.5, 6.5 Hz, 1 H), 3.43 (t, J = 9.5 Hz, 1 H), 3.29–3.21 (m, 4 H), 2.92–2.86 (m, 1 H), 2.44 (s, 3 H), 2.06 (s, 3 H), 1.63 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 195.6, 178.5, 178.4, 175.6, 146.4, 145.5, 139.7, 138.0, 135.4, 134.5, 130.2, 129.5, 129.3, 129.2, 129.1, 129.0, 128.5, 128.3, 127.4, 127.4, 126.9, 124.6, 121.7, 108.9, 60.0, 58.9, 56.3, 53.5, 30.6, 26.5, 25.4, 18.3, 18.1.

HRMS (ESI): m/z [M + Na]+ calcd for C37H32N2NaO4: 591.2260; found: 591.2259.


#

5-Benzoyl-3a-benzyl-2-(2,6-dimethylphenyl)-1′-methyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8i)

White solid; yield: 102.2 mg (36%); mp 293–294 °C.

1H NMR (500 MHz, CDCl3): δ = 7.86 (d, J = 7.5 Hz, 2 H), 7.57 (t, J = 7.5 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.36 (t, J = 7.5 Hz, 1 H), 7.28–7.26 (m, 4 H), 7.20–7.18 (m, 2 H), 7.10–7.01 (m, 3 H), 6.96 (d, J = 8.0 Hz, 1 H), 6.85 (d, J = 7.0 Hz, 1 H), 4.73 (dd, J = 13.0, 8.0 Hz, 1 H), 3.88 (dd, J = 10.0, 7.0 Hz, 1 H), 3.46 (d, J = 13.0 Hz, 1 H), 3.30–3.21 (m, 4 H), 3.12 (d, J = 13.0 Hz, 1 H), 2.93–2.87 (m, 1 H), 2.31 (s, 3 H), 0.92 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 196.3, 177.5, 176.4, 174.6, 145.9, 137.6, 135.9, 135.6, 134.7, 133.7, 131.5, 130.4, 129.5, 129.3, 129.0, 128.9, 128.8, 128.5, 128.2, 127.9, 126.3, 125.0, 121.8, 109.2, 60.8, 60.1, 59.3, 46.9, 41.7, 29.1, 26.6, 18.9, 16.9.

HRMS (ESI): m/z [M + Na]+ calcd for C37H32N2NaO4: 591.2260; found: 591.2255.


#

5-Benzoyl-2-(2,6-dimethylphenyl)-3a-(3-fluorobenzyl)-1′-methyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8j)

White solid; yield: 146.5 mg (50%); mp 299–300 °C.

1H NMR (500 MHz, CDCl3): δ = 7.85 (d, J = 7.5 Hz, 2 H), 7.56 (t, J = 7.5 Hz, 1 H), 7.45 (t, J = 7.7 Hz, 2 H), 7.36 (t, J = 7.3 Hz, 1 H), 7.27–7.23 (m, 2 H), 7.11–6.88 (m, 8 H), 4.72 (dd, J = 13.0, 8.5 Hz, 1 H), 3.82 (dd, J = 10.0, 7.0 Hz, 1 H), 3.45 (d, J = 13.0 Hz, 1 H), 3.30–3.22 (m, 4 H), 3.12 (d, J = 13.0 Hz, 1 H), 2.93–2.87 (m, 1 H), 2.32 (s, 3 H), 1.04 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 196.2, 177.4, 176.2, 174.5, 164.1, 162.1, 145.9, 137.6, 137.3, 137.2, 135.9, 135.4, 133.8, 130.8, 130.7, 130.4, 129.6, 129.1, 129.0, 128.9, 128.5, 128.3, 127.2, 127.2, 126.1, 124.9, 121.8, 118.6, 118.4, 115.0, 114.8, 109.2, 60.7, 60.2, 59.2, 47.0, 41.4, 29.1, 26.6, 18.9, 16.9.

HRMS (ESI): m/z [M + Na]+ calcd for C37H31FN2NaO4: 609.2166; found: 609.2164.


#

5-Benzoyl-3a-(3-chlorobenzyl)-2-(2,6-dimethylphenyl)-1′-methyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8k)

White solid; yield: 117.4 mg (39%); mp 303–304 °C.

1H NMR (500 MHz, CDCl3): δ = 7.86 (d, J = 7.5 Hz, 2 H), 7.57 (t, J = 7.0 Hz, 1 H), 7.46 (t, J = 7.5 Hz, 2 H), 7.36 (t, J = 7.5 Hz, 1 H), 7.27–7.19 (m, 4 H), 7.12–6.96 (m, 5 H), 6.89 (d, J = 7.0 Hz, 1 H), 4.70 (dd, J = 13.0, 8.0 Hz, 1 H), 3.81 (dd, J = 9.5, 7.5 Hz, 1 H), 3.42 (d, J = 13.0 Hz, 1 H), 3.29–3.23 (m, 4 H), 3.10 (d, J = 13.0 Hz, 1 H), 2.94–2.88 (m, 1 H), 2.32 (s, 3 H), 1.04 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 196.2, 177.4, 176.2, 174.6, 145.9, 137.6, 136.8, 135.9, 135.4, 135.1, 133.8, 131.5, 130.5, 130.3, 129.7, 129.6, 129.1, 129.0, 128.9, 128.5, 128.3, 128.2, 126.1, 124.9, 121.8, 109.2, 60.6, 60.2, 59.2, 47.0, 41.4, 29.2, 26.6, 18.9, 16.9.

HRMS (ESI): m/z [M + Na]+ calcd for C37H31ClN2NaO4: 625.1870; found: 625.1863.


#

Ethyl 2-(5-Benzoyl-2-(2,6-dimethylphenyl)-1′-methyl-1,2′,3-trioxo-2,3,3a,5,6,6a-hexahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indolin]-3a-yl)acetate (8l)

White solid; yield: 163.6 mg (58%); mp 248–249 °C.

1H NMR (500 MHz, CDCl3): δ = 7.84 (d, J = 7.5 Hz, 2 H), 7.54 (t, J = 7.5 Hz, 1 H), 7.42 (t, J = 7.5 Hz, 2 H), 7.30 (t, J = 7.5 Hz, 1 H), 7.19 (t, J = 7.5 Hz, 1 H), 7.14–7.11 (m, 2 H), 7.06 (d, J = 7.5 Hz, 1 H), 6.97 (t, J = 7.5 Hz, 1 H), 6.88 (d, J = 8.0 Hz, 1 H), 4.94 (dd, J = 13.5, 7.5 Hz, 1 H), 4.32–4.12 (m, 3 H), 3.23–3.17 (m, 4 H), 3.02 (d, J = 17.5 Hz, 1 H), 2.99–2.93 (m, 1 H), 2.87 (d, J = 17.5 Hz, 1 H), 2.43 (s, 3 H), 2.08 (s, 3 H), 1.32 (t, J = 7.0 Hz, 3 H).

13C NMR (125 MHz, CDCl3): δ = 196.6, 178.3, 176.8, 176.0, 171.1, 145.8, 137.9, 135.9, 135.8, 133.6, 130.1, 129.6, 129.3, 129.2, 128.8, 128.5, 128.4, 126.5, 124.2, 121.9, 109.1, 61.6, 60.0, 59.9, 57.8, 49.5, 39.9, 30.8, 26.5, 18.5, 18.4, 14.3.

HRMS (ESI): m/z [M + Na]+ calcd for C34H32N2NaO6: 587.2158; found: 587.2159.


#

5-Benzoyl-4′-bromo-2-(2,6-dimethylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8m)

White solid; yield: 128.3 mg (45%); mp 314–315 °C.

1H NMR (500 MHz, CDCl3): δ = 7.81 (d, J = 7.0 Hz, 2 H), 7.53 (t, J = 7.5 Hz, 1 H), 7.41 (t, J = 7.5 Hz, 2 H), 7.20 (t, J = 7.5 Hz, 1 H), 7.17–7.13 (m, 3 H), 7.07 (d, J = 7.5 Hz, 1 H), 6.83–6.79 (m, 1 H), 5.78 (dd, J = 13.5, 7.0 Hz, 1 H), 3.47 (dd, J = 10.0, 8.5 Hz, 1 H), 3.27–3.18 (m, 4 H), 2.98–2.92 (m, 1 H), 2.38 (s, 3 H), 2.06 (s, 3 H), 1.83 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 197.2, 178.9, 178.3, 175.4, 147.8, 137.7, 136.1, 135.5, 133.5, 130.7, 129.9, 129.5, 129.1, 128.8, 128.3, 127.5, 125.4, 119.9, 108.3, 61.2, 59.7, 56.2, 53.6, 31.4, 26.5, 24.0, 18.1, 18.0.

HRMS (ESI): m/z [M + Na]+ calcd for C31H27BrN2NaO4: 593.1052; found: 593.1048.


#

5-Benzoyl-5′-chloro-2-(2,6-dimethylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8n)

White solid; yield: 89.4 mg (34%); mp 241–242 °C.

1H NMR (500 MHz, CDCl3): δ = 7.45 (td, J = 7.5, 1.3 Hz, 3 H), 7.32–7.14 (m, 6 H), 7.08 (d, J = 7.5 Hz, 1 H), 6.51 (d, J = 8.5 Hz, 1 H), 4.49 (t, J = 8.0 Hz, 1 H), 3.49 (dd, J = 10.0, 8.0 Hz, 1 H), 3.15–3.09 (m, 1 H), 2.93 (s, 3 H), 2.82–2.75 (m, 1 H), 2.35 (s, 3 H), 2.06 (s, 3 H), 1.63 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 198.8, 177.1, 176.1, 175.9, 142.1, 136.9, 136.6, 135.7, 133.3, 130.1, 129.6, 129.3, 129.2, 128.8, 128.5, 128.3, 128.0, 127.8, 127.3, 108.8, 60.8, 58.8, 55.3, 52.7, 31.6, 26.5, 23.5, 18.7, 18.4.

HRMS (ESI): m/z [M + Na]+ calcd for C31H27ClN2NaO4: 549.1557; found: 549.1559.


#

5-Benzoyl-2-(2-chloro-6-methylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8o)

White solid; yield: 115.2 mg (45%); mp 279–280 °C.

1H NMR (500 MHz, CDCl3): δ = 7.40–7.14 (m, 10 H), 6.98 (t, J = 8.0 Hz, 1 H), 6.53 (d, J = 8.0 Hz, 1 H), 4.39 (dd, J = 10.5, 6.5 Hz, 1 H), 3.47 (dd, J = 9.5, 3.0 Hz, 1 H), 3.10–3.04 (m, 1 H), 2.91–2.87 (m, 1 H), 2.77 (s, 3 H), 2.65 (s, 3 H), 1.29 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 198.9, 178.2, 176.6, 176.4, 143.8, 139.9, 137.1, 132.8, 132.6, 130.4, 129.7, 129.4, 129.2, 128.1, 128.1, 127.4, 127.2, 125.6, 122.2, 108.4, 62.7, 58.7, 56.1, 54.0, 30.5, 26.4, 22.9, 18.6.

HRMS (ESI): m/z [M + H]+ calcd for C30H26ClN2O4: 513.1581; found: 513.1595.


#

2-(2-Chloro-6-methylphenyl)-5-(4-chlorobenzoyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8p)

White solid; yield: 128.3 mg (47%); mp 282–283 °C.

1H NMR (500 MHz, CDCl3): δ = 7.72 (d, J = 8.5 Hz, 2 H), 7.38 (d, J = 8.5 Hz, 2 H), 7.31–7.21 (m, 4 H), 7.18 (d, J = 7.5 Hz, 1 H), 7.00 (t, J = 7.5 Hz, 1 H), 6.86 (d, J = 7.5 Hz, 1 H), 4.46 (dd, J = 13.5, 7.0 Hz, 1 H), 3.45 (t, J = 9.5 Hz, 1 H), 3.22–3.10 (m, 4 H), 2.82–2.76 (m, 1 H), 2.45 (s, 3 H), 1.65 (s, 3 H).

13C NMR (125 MHz, CDCl3): δ = 195.1, 178.3, 177.5, 175.1, 145.4, 140.7, 140.2, 134.2, 132.5, 130.4, 129.9, 129.8, 129.4, 129.2, 129.0, 127.3, 126.7, 124.5, 121.8, 109.0, 59.7, 58.9, 56.4, 53.3, 30.1, 26.4, 24.9, 18.6.

HRMS (ESI): m/z [M + Na]+ calcd for C30H24Cl2N2NaO4: 569.1011; found: 569.1018.


#

5-(4-Chlorobenzoyl)-2-(2,6-diisopropylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8q)

White solid; yield: 177.5 mg (61%); mp 272–273 °C.

1H NMR (500 MHz, CDCl3): δ = 7.76 (d, J = 8.5 Hz, 2 H), 7.30–7.37 (m, 3 H), 7.30–7.27 (m, 2 H), 7.18–7.17 (m, 2 H), 6.98 (t, J = 7.5 Hz, 1 H), 6.87 (d, J = 7.5 Hz, 1 H), 4.47 (dd, J = 13.5, 6.5 Hz, 1 H), 3.45–3.36 (m, 2 H), 3.30–3.23 (m, 4 H), 2.83–2.78 (m, 1 H), 2.59–2.51 (m, 1 H), 1.61 (s, 3 H), 1.24 (d, J = 3.5 Hz, 3 H), 1.23 (d, J = 3.0 Hz, 3 H), 1.16 (d, J = 7.0 Hz, 3 H), 1.08 (d, J = 7.0 Hz, 3 H).

13C NMR (125 MHz, CDCl3): δ = 195.0, 179.0, 178.2, 176.6, 148.6, 145.5, 145.4, 140.2, 134.1, 130.2, 129.9, 129.3, 129.2, 127.4, 126.7, 124.8, 124.4, 123.6, 121.6, 108.9, 59.6, 58.5, 56.1, 53.3, 30.1, 29.2, 27.9, 26.3, 25.6, 25.0, 24.1, 23.9, 23.8.

HRMS (ESI): m/z [M + Na]+ calcd for C35H35ClN2NaO4: 605.2183; found: 605.2189.


#

5-Benzoyl-2-(2,6-diisopropylphenyl)-1′,3a-dimethyl-3a,5,6,6a-tetrahydro-1H-spiro[cyclopenta[c]pyrrole-4,3′-indoline]-1,2′,3(2H)-trione (8r)

White solid; yield: 95.9 mg (35%); mp 285–286 °C.

1H NMR (500 MHz, CDCl3): δ = 7.83 (d, J = 7.5 Hz, 2 H), 7.54 (t, J = 7.5 Hz, 1 H), 7.44–7.37 (m, 3 H), 7. 28 (t, J = 8.5 Hz, 2 H), 7.17 (d, J = 7.5 Hz, 2 H), 6.97 (t, J = 7.5 Hz, 1 H), 6.87 (d, J = 7.5 Hz, 1 H), 4.54 (dd, J = 13.5, 7.0 Hz, 1 H), 3.46–3.38 (m, 2 H), 3.31–3.24 (m, 4 H), 2.88–2.82 (m, 1 H), 2.56 (dt, J = 13.5, 7.0 Hz, 1 H), 1.62 (s, 3 H), 1.25–1.23 (m, 6 H), 1.16 (d, J = 7.0 Hz, 3 H), 1.09 (d, J = 6.5 Hz, 3 H).

13C NMR (125 MHz, CDCl3): δ = 196.1, 179.1, 178.4, 176.7, 148.6, 145.5, 145.4, 135.8, 133.7, 130.1, 129.2, 128.8, 128.5, 127.5, 126.9, 124.8, 124.4, 123.6, 121.6, 108.9, 59.7, 58.5, 56.2, 53.3, 30.2, 29.2, 27.9, 26.3, 25.6, 25.0, 24.1, 23.9, 23.8.

HRMS (ESI): m/z [M + Na]+ calcd for C35H36N2NaO4: 571.2573; found: 571.2568.


#

Ethyl 5-Benzoyl-2-[(2,6-diisopropylphenyl)carbamoyl]-1′,2-dimethyl-2′-oxospiro[cyclopentane-1,3′-indoline]-3-carboxylate (9a)

White solid; yield: 41.6 mg (14%); mp 224–225 °C.

1H NMR (500 MHz, CDCl3): δ = 7.30–7.27 (m, 1 H), 7.23 (d, J = 7.0 Hz, 1 H), 7.15–7.11 (m, 5 H), 7.04–6.99 (m, 3 H), 6.79 (td, J = 7.5, 1.0 Hz, 1 H), 6.50 (s, 1 H), 6.33 (d, J = 7.5 Hz, 1 H), 4.33 (dd, J = 11.0, 7.5 Hz, 1 H), 4.28–4.15 (m, 2 H), 3.62 (m, 1 H), 3.28 (dd, J = 13.0, 6.5 Hz, 1 H), 2.84 (s, 3 H), 2.49–2.43 (m, 1 H), 1.92 (s, 3 H), 1.61 (s, 2 H), 1.32 (t, J = 7.5 Hz, 3 H), 0.92 (s, 6 H), 0.91 (s, 6 H).

13C NMR (125 MHz, CDCl3): δ = 198.6, 178.2, 172.6, 170.5, 143.4, 138.0, 132.0, 130.9, 129.2, 129.1, 127.9, 127.8, 127.7, 126.8, 123.4, 123.1, 107.1, 62.1, 60.8, 60.4, 54.8, 54.8, 31.0, 27.6, 26.4, 24.4, 14.4.

HRMS (ESI): m/z [M + Na]+ calcd for C37H42N2NaO5: 617.2991; found: 617.2987.


#

Ethyl 5-Benzoyl-5′-bromo-2-[(2,6-dimethylphenyl)carbamoyl]-1′,2-dimethyl-2′-oxospiro[cyclopentane-1,3′-indoline]-3-carboxylate (9b)

White solid; yield: 129.4 mg (42%); mp 271–272 °C.

1H NMR (500 MHz, CDCl3): δ = 7.24 (t, J = 7.5 Hz, 1 H), 7.17–7.14 (m, 3 H), 7.11–7.08 (m, 3 H), 7.01–6.92 (m, 3 H), 6.72 (s, 1 H), 6.20 (d, J = 8.5 Hz, 1 H), 4.35 (dd, J = 11.5, 7.0 Hz, 1 H), 4.26–4.12 (m, 2 H), 3.78 (q, J = 12.5 Hz, 1 H), 3.37 (dd, J = 13.0, 7.0 Hz, 1 H), 2.97 (s, 3 H), 2.49–2.44 (m, 1 H), 1.76 (s, 3 H), 1.71 (s, 6 H), 1.31 (t, J = 7.0 Hz, 3 H).

13C NMR (125 MHz, CDCl3): δ = 197.9, 178.7, 172.3, 169.5, 142.7, 138.2, 134.8, 133.1, 132.0, 131.8, 131.7, 128.8, 128.2, 127.9, 127.5, 126.9, 116.2, 108.7, 62.5, 61.0, 59.7, 54.4, 54.0, 31.1, 26.6, 22.2, 18.1, 14.3.

HRMS (ESI): m/z [M + Na]+ calcd for C33H33BrN2NaO5: 639.1471; found: 639.1468.


#
#

Acknowledgement

The authors thank the National Natural Science Foundation of China (Nos: 21272148, 21272147, 21472121), and the State Key Laboratory of Applied Organic Chemistry, Lanzhou University for financial support. The authors also thank Dr. Hongmei Deng and Min Shao of Laboratory for Microstructures, Shanghai University for the NMR and single crystal X-ray analysis.

Supporting Information



Zoom Image
Scheme 1 Representative multicomponent cycloadditions based on isocyanide and allenoate in the presence of electron-deficient species
Zoom Image
Figure 1 X-ray crystal structure of product 5d
Zoom Image
Scheme 2 Proposed mechanism
Zoom Image
Scheme 3 Controlled experiments
Zoom Image
Scheme 4 Construction of spirocyclic oxindole 8 with aromatic isocyanides
Zoom Image
Figure 2 X-ray crystal structure of product 9a
Zoom Image
Scheme 5 Different regioselectivity observed during the Michael addition with substrates 7 and 3
Zoom Image
Scheme 6 Formation of an interesting product 9
Zoom Image
Scheme 7 Proposed mechanism for the formation of compound 9
Zoom Image
Scheme 8 Conversion between compound 9 and 8